News & Updates

Show Multimedia Only

Management of allergic rhinitis – focus on Bilaxten

14 Jan 2022

Allergic rhinitis can induce two types of symptoms in patients: i) histamine-mediated symptoms such as vasodilatation, rhinorrhoea, itching and sneezing, and ii) allergic inflammation resulting from the action of eosinophils in the nasal lining. H1-antihistamine therapy is a mode of therapy that seeks to mitigate the histamine-mediated symptoms of allergic rhinitis; this therapy aims to relieve symptoms and to improve quality of life in patients.

Management of allergic rhinitis – focus on Bilaxten

14 Jan 2022

Smokers more likely to develop COVID-19 complications

13 Jan 2022

Among patients with COVID-19 infection, those who smoke are at higher risk of developing complications compared with those who do not smoke, according to a study from Malaysia.

Smokers more likely to develop COVID-19 complications

13 Jan 2022

COVID-19 vax tied to small, transient change in menstrual cycle length

11 Jan 2022 by

COVID-19 vaccination appears to be associated with a small increase in menstrual cycle length of less than 1 day, but these changes are only temporary and there is no change in the duration of menses, a prospective study suggests.

COVID-19 vax tied to small, transient change in menstrual cycle length

11 Jan 2022

Intensive rehab benefits lung cancer patients undergoing surgery

11 Jan 2022 by

A rehabilitation programme comprising intensive perioperative pulmonary rehabilitation (PR) and standard of care (SC) led to improved exercise capacity and tolerance in individuals with early-stage non-small-cell lung cancer (NSCLC) who are undergoing lung resection, the PUREAIR trial suggests.

Intensive rehab benefits lung cancer patients undergoing surgery

11 Jan 2022

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

06 Jan 2022

New drug applications approved by US FDA as of 16-31 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

06 Jan 2022

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022 by

Treatment with icosapent ethyl did not reduce the rate of hospitalization or mortality among patients with SARS-CoV-2 infection, according to results of the PREPARE IT-2* trial presented at AHA 2021.

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022

Lower risk of SARS-CoV-2 after booster dose

03 Jan 2022 by

Receipt of a booster dose of the BNT162b2 mRNA vaccine is tied to a reduced risk of testing positive for SARS-CoV-2, according to results of a study from Israel.

Lower risk of SARS-CoV-2 after booster dose

03 Jan 2022

First chronic obstructive pulmonary disease exacerbation predicts risk of more

02 Jan 2022

Exacerbation history, along with the presence of severe dyspnoea and maintenance treatment use, is associated with an increased risk of future exacerbation episodes in patients with chronic obstructive pulmonary disease, a study has found.

First chronic obstructive pulmonary disease exacerbation predicts risk of more

02 Jan 2022

COVID-19 vax in kids: Which group to target first?

30 Dec 2021 by

Children with asthma who are infected with SARS-CoV-2 virus are at an increased risk of hospitalization, especially those whose asthma is poorly controlled, compared with children without asthma, according to data from the EAVE II* study.

COVID-19 vax in kids: Which group to target first?

30 Dec 2021

Omicron raises new fears

28 Dec 2021 by

The threat of Omicron is real, with scientists working at breakneck speed to better understand its virulence and potential ability to evade currently approved vaccines.

Omicron raises new fears

28 Dec 2021

News & Updates

Filter by Specialty:

Specialty:

Management of allergic rhinitis – focus on Bilaxten

Management of allergic rhinitis – focus on Bilaxten

Smokers more likely to develop COVID-19 complications

Smokers more likely to develop COVID-19 complications

COVID-19 vax tied to small, transient change in menstrual cycle length

COVID-19 vax tied to small, transient change in menstrual cycle length

Intensive rehab benefits lung cancer patients undergoing surgery

Intensive rehab benefits lung cancer patients undergoing surgery

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

No reduction in COVID-19 hospitalization, death with icosapent ethyl

No reduction in COVID-19 hospitalization, death with icosapent ethyl

Lower risk of SARS-CoV-2 after booster dose

Lower risk of SARS-CoV-2 after booster dose

First chronic obstructive pulmonary disease exacerbation predicts risk of more

First chronic obstructive pulmonary disease exacerbation predicts risk of more

COVID-19 vax in kids: Which group to target first?

COVID-19 vax in kids: Which group to target first?

Omicron raises new fears

Omicron raises new fears